Thursday, November 12, 2026

Intel Ships 1.15 Billion Neuron Neuromorphic Chip as Brain-Inspired Computing Reaches Production Scale

Neuromorphic computing is transitioning from research to commercial deployment, with Intel's Hala Point system delivering 1.15 billion neurons and BrainChip deploying Akida chips in production IoT devices. The shift addresses energy efficiency demands as AI workloads expand beyond traditional GPU architectures, while NVIDIA's Rubin Ultra roadmap extends to 2027 and Amkor's Arizona packaging campus targets 2028 completion.

Intel Ships 1.15 Billion Neuron Neuromorphic Chip as Brain-Inspired Computing Reaches Production Scale
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Intel's Hala Point neuromorphic system reached production with 1.15 billion neurons, marking a shift from experimental brain-inspired chips to deployable AI hardware. The architecture mimics biological neural networks to reduce power consumption compared to GPU-based inference systems.

BrainChip's Akida neuromorphic processor entered commercial deployment in edge IoT applications, processing sensor data locally without cloud connectivity. The event-driven architecture activates circuits only when processing input, cutting standby power draw in battery-operated devices.

Traditional accelerator roadmaps continue in parallel. NVIDIA scheduled Rubin Ultra for 2027 release, while Corvex integrated confidential computing capabilities into HGX B200 platforms for enterprises requiring encrypted AI workloads. VCI Global launched Intelli-X, an enterprise AI platform combining multiple accelerator types for data center deployments.

Amkor's Arizona campus will add advanced packaging capacity by 2028, addressing chiplet integration demands from both neuromorphic and conventional AI architectures. The facility targets high-bandwidth memory stacking and 3D chip assembly for compute-intensive applications.

Aehr Test Systems reported $6.2 million in Q2 FY2026 bookings, down from $11.4 million in Q1, but projected $60-80 million in orders for the second half driven by AI wafer-level testing demand. The company's lead Sonoma customer provided forecasts for Q1 FY2027 shipments starting May 30, 2026, supporting AI ASIC production ramps.

Credo Technology Group forecast 63.8-65.8% GAAP gross margins for Q3 FY2026, reflecting pricing power in connectivity chips linking AI accelerators within data center racks. High-speed interconnects between processors become critical as model sizes exceed single-chip memory capacity.

Ensurge Micropower positioned its microbattery technology for AI-enabled edge devices, where neuromorphic chips require compact power sources. The convergence of low-power processing and miniaturized batteries enables new form factors for wearable and embedded AI applications.

The hardware landscape now spans neuromorphic edge processors, traditional GPU clusters, and hybrid systems combining both approaches. Energy efficiency requirements drive adoption curves as training and inference workloads multiply across industries.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score11 source documents11 with a live linkVerifiability: High
  1. [1]Earnings callNasdaq· January 16, 2026
    Aehr Test (AEHR) Q2 2026 Earnings Call Transcript
  2. [2]News articleYahoo Finance· December 1, 2025
    Credo Technology Group Holding Ltd Reports Second Quarter of Fiscal Year 2026 Financial Results
  3. [3]News articleYahoo Finance· February 10, 2026
    Einride to Appoint Former NVIDIA Executive Gary Hicok to Board of Directors
  4. [4]Press releaseGlobeNewswire· December 5, 2025
    Ensurge Micropower ASA – Commencement of subscription period in the Subsequent Offering
  5. [5]Press releaseGlobeNewswire· November 6, 2025
    Ensurge Micropower ASA – Contemplated private placement
  6. [6]News articleYahoo Finance· December 5, 2025
    Stock market today: S&P 500, Nasdaq, Dow rise as Fed-favored PCE inflation data cools
  7. [7]News articleYahoo Finance· March 3, 2026
    Corvex Among the First Companies to Achieve Verified Production Deployment of Confidential Computing for AI on NVIDIA HGX™ B200 Systems
  8. [8]News articleYahoo Finance· February 4, 2026
    Silicon Motion Technology Q4 Earnings Call Highlights
  9. [9]News articleYahoo Finance· February 24, 2026
    The Zacks Analyst Blog Highlights Amphenol, Western Digital, Vertiv, Lumentum and EMCOR
  10. [10]News articleYahoo Finance· March 4, 2026
    VCI Global’s V Gallant Launches Malaysia’s First NVIDIA-Powered AI GPU Computing Center; Debuts Intelli-X Enterprise LLM Platform
  11. [11]Press releaseGlobeNewswire· December 11, 2025
    Wafer Dicing Services Market Set to Exceed US$ 932.9 Million by 2035 | Astute Analytica

In this story

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com